Lottie Moss Warns of Ozempic Dangers After Hospitalization

Lottie Moss, the younger sister of supermodel Kate Moss, has issued a warning to anyone considering taking Ozempic after experiencing severe side effects that led to hospitalization. Moss claims she took the weight-loss drug for two weeks several months ago and suffered extreme nausea and rapid weight loss, eventually leading to a seizure due to dehydration.

Lottie Moss, the 26-year-old model and sister of Kate Moss, has shared her harrowing experience with Ozempic, a weight-loss drug that has become increasingly popular in recent months. Moss took Ozempic for two weeks "a few months ago" in an attempt to address her dissatisfaction with her weight, but the consequences were severe.

Lottie Moss Warns of Ozempic Dangers After Hospitalization

Lottie Moss Warns of Ozempic Dangers After Hospitalization

During an episode of her "Dream On with Lottie Moss" podcast, Moss admitted that she obtained Ozempic "below board" from a doctor, emphasizing that proper medical supervision and testing are crucial before taking the drug. However, Moss's experience with Ozempic was anything but safe.

"It was the worst decision I ever made," Moss said. "It made me feel so nauseous." She recalled vomiting constantly and losing nearly 20 pounds in a matter of weeks, a significant and unhealthy weight drop.

Lottie Moss Warns of Ozempic Dangers After Hospitalization

Lottie Moss Warns of Ozempic Dangers After Hospitalization

Moss explained that the dose she was taking was intended for individuals weighing over 220 pounds, while she was in the 110-pound range. This disparity in dosage further contributed to her severe side effects.

After struggling with persistent nausea and dehydration, Moss sought medical attention at the emergency room, where she suffered a seizure. She credits her hospitalization with ultimately saving her life.

Lottie Moss Warns of Ozempic Dangers After Hospitalization

Lottie Moss Warns of Ozempic Dangers After Hospitalization

Moss strongly discourages anyone from taking Ozempic, emphasizing the potential dangers and the importance of seeking proper medical advice before embarking on any weight-loss journey.

"When I tell you it was the worst decision I ever made, so if this is a warning to anyone: Please, if you're thinking of taking it, do not take it, it's so not worth it," Moss said. "I would rather die any day than take that again."

Novo Nordisk, the manufacturer of Ozempic, released a statement expressing concern for Moss's health challenges and emphasizing the importance of close patient monitoring by healthcare professionals. The company stressed that Ozempic is a prescription-only medicine and should only be taken under the supervision of a doctor.

Accessing prescription-only medicines without a valid prescription poses a direct danger to health, Novo Nordisk warned. The company also noted that patient safety is their top priority and that they work closely with regulatory agencies to monitor the safety of their products.

Moss's experience serves as a cautionary tale about the potential risks associated with using Ozempic without proper medical oversight. Individuals considering weight-loss options should always consult with their healthcare provider to determine the safest and most effective approach for their individual needs.